(Q54697861)

3 June 2018

title

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study. (English)

1 reference

3 June 2018

0 references

Mukesh Nasa

1

1 reference

3 June 2018

Ajay Choksey

series ordinal

2

1 reference

3 June 2018

Aniruddha Phadke

series ordinal

3

1 reference

3 June 2018

Prabha Sawant

series ordinal

4

1 reference

3 June 2018

language of work or name

English

0 references

publication date

26 October 2013

1 reference

3 June 2018

Indian Journal of Gastroenterology

published in

1 reference

3 June 2018

volume

32

1 reference

3 June 2018

issue

6

1 reference

3 June 2018

page(s)

392-396

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1007/s12664-013-0357-7

exact match

0 references

cites work

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Seven-day therapy for Helicobacter pylori in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Two new treatment regimens for Helicobacter pylori eradication: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

High eradication rates of Helicobacter pylori with a new sequential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-013-0357-7

Helicobacter pylori eradication: efficacy of conventional therapy in India

21 January 2018

1 reference

12 December 2020

Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India

1 reference

12 December 2020

Helicobacter pylori infection in India: the case against eradication.

1 reference

12 December 2020

Epidemiology of Helicobacter pylori infection

1 reference

12 December 2020

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial

1 reference

12 December 2020

Association of peptic ulcer with Helicobacter pylori and the recurrence rate. A three year follow-up study

1 reference

12 December 2020

Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure

1 reference

12 December 2020

Eradication of Helicobacter pylori for non-ulcer dyspepsia

1 reference

12 December 2020

Acquisition of Helicobacter pylori infection and reinfection after its eradication are uncommon in Indian adults

1 reference

12 December 2020

Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.

1 reference

12 December 2020

10.1007/S12664-013-0357-7

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018